Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7962 analgesic efficacy in osteoarthritis of the knee (Phase 2a)
2014-004996-22Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ASP7962 in knee osteoarthritis (OA) (3 arms), sponsored by Astellas Pharma. Primary endpoint: Change from baseline to week 4 in WOMAC pain subscale score. Started Dec 2015; status: completed.
02
Drugs
ASP7962
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2014-004996-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004996-22.